Literature DB >> 3079316

Clinical applications of colony-stimulating factors.

J D Griffin1.   

Abstract

There are at least four known human colony-stimulating factors (CSFs) which can stimulate proliferation of specific types of hematopoietic progenitor cells in vitro and in vivo: IL-3, GM-CSF, G-CSF, and M-CSF. In animal studies and preliminary human trials, at least two of these CSFs have been shown to accelerate granulocyte recovery following cytotoxic chemotherapy. The CSFs may ultimately have far-reaching effects on the practice of oncology, permitting higher doses of cytotoxic drugs and radiation, allowing design of more aggressive drug schedules, decreasing infectious complications and hospital stays, and diminishing the morbidity of marrow transplantation. The author describes the functions, cellular sources, and potential uses of the colony-stimulating factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3079316

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  2 in total

Review 1.  Use and toxicity of the colony-stimulating factors.

Authors:  J R Schriber; R S Negrin
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

2.  The effects of p38 MAPK inhibition combined with G-CSF administration on the hematoimmune system in mice with irradiation injury.

Authors:  Deguan Li; Yueying Wang; Hongying Wu; Lu Lu; Xiaochun Wang; Junling Zhang; Heng Zhang; Saijun Fan; Feiyue Fan; Daohong Zhou; Aimin Meng
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.